chrisvoncsefalvay/vaers-outcomes huggingface dataset:
December 31st I started feeling like I was sick, aches throughout my body, fever, and a cough. I had no energy and a sore throat. It got worse on the 1st, but the fever went down with Tylenol. On the 2nd I thought I had the Flu because of how bad my body felt and all I could do was sit, the same on the 3rd. On the 4th I called my doctor thinking I had the Flu and we had a tele-health visit. She started me on steroids and an inhaler. I had taken COVID19 tests at home on the 1st and 3rd that were negative so I was still thinking it was the flu. The inhaler helped with the cough a little bit. I started an antibiotic on 1/6 because she thought I was getting pneumonia. I still wasn't better by the 7th and by the 10th I had finished the oral steroids. On the 11th I called the doctor back because I had an ear ache, and was still coughing and aching. The 13th I had another telehealth visit and they prescribed another antibiotic and switched to a steroid inhaler. I was still getting food delivered by friends on the 16th and by the 17th I finally felt like I could get up and do things. By the 18th I could do some daily living stuff and the 19th I was able to leave the house for the first time. Over the course my sense of taste and smell were really strange. My sense of smell started on 1/3 and I could smell things but I was smelling things that weren't there like Lavender and Vanilla. My taste faded as well. Talking with my doctor towards the end of it we thought it may have been a missed diagnosed COVID19 incident but it was too late to do anything from that. Since then I still have no energy, I just sit now when I normally have a lot of energy, and I've been having issues remembering words.
After sitting 15 minutes I walked back to my department and my left forearm and hand was feeling pin pricks. I had numbness and tingling sensations for about 2 hours after the injection with no other symptoms. Did not need to seek medical attention. The next day I was severely fatigued and dehydrated. The arm with the injection was incredibly sore. All symptoms were gone day two after injection. One week after injection large raised, red bump appeared at injection sight. The spot was slightly sore an itchy.
Vaccine given at onsite workplace clinic at 8:50 am. 20 minutes after vaccination patient reports becoming dizzy. 30 minutes after vaccination he became very nauseous and had 2 episodes of dry heaving. He went home from work around 10:10 am and reported increasing dizziness and nausea at this time as well has body aches and feeling "feverish." By 2 pm he reported vomiting 4-5 times. He reported having a 100 degree F fever and took some TYLENOL. Later in evening he went to the ER because he could not stop vomiting and was in severe pain all over and was hypersensitive to physical stimulus. He was given fluids and antiemetics and had bloodwork done. Was given prescription for ZOFRAN and was sent home. The next day he reported he was feeling a bit better because the ZOFRAN was decreasing his nausea and he was less achy than before but he still is running a temp of 99-100.
8-13-12 1340 mother returned with child to health dept. He received PCV 13 and MMR in his left thigh on 8-10-12. She stated the following morning it was red and swollen and tender to touch. At present, there is a 2 1/2 inch circular area on his left upper thigh that is red, slightly swollen and "less" tender to touch according to mother.
Shot given left deltoid on 9/1/04. Pt came on 9/1/04 with left deltoid showing redness and swelling 32cm. No systemic firm only localized reaction noted. Reported on start, swelling and was sore since 9/2/04.
Patient experienced swelling and pain at the injection site.  Stated the pain started same day as the vaccination administration
This spontaneous report as received from a other health professional refers to an unspecified number of patients of unknown age. On an unknown date, the patient were vaccinated with M-M-R II lot # M042846 with an expiration date 21-OCT-2018 and lot# M044351 with an expiration date 04-NOV-2018 for prophylaxis. On an unknown date, the patients experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to M-M-R II. This is one of two reports received from the same reporter.; Sender's Comments: US-009507513-1709USA001301:
A non-serious spontaneous report of administration of expired FLUMIST was received from a nurse concerning a 23-year-old male. Neither medical history nor concomitant medications were reported. On 17-Feb-2009, the patient received expired FLUMIST vaccine. The vaccine had an expiration date of 11-Jan-2009. As of 18-Mar-2009, there was no adverse events associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. Based on the results of the investigation, the root cause of the medication errors were caused by 1) customers not discarding product from previous season and 2) product expiring during the peak of flu season resulting in some medication errors that occurred shortly after the product expired. Additional information was received on 12-May-2009 and incorporated into the narrative: Product complaint investigation results.
I have tinnitus in both ears. This turned on like a switch when I woke up in the morning. I do not have hearing loss. This overrides my hearing on a 24/7 basis. I am currently making doctor appointments to have testing performed.
SWEATY; SWOLLEN LIP; CHILLS; TIRED; FEVERISH; ITCHY FOREARMS; FLU-LIKE SYMPTOMS; ACHEY; This spontaneous report received from a patient concerned a 56 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced itchy forearms. On APR-2021, the subject experienced flu-like symptoms. On APR-2021, the subject experienced achey. On APR-2021, the subject experienced tired. On APR-2021, the subject experienced feverish. On an unspecified date, the subject experienced sweaty, swollen lip, and chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the flu-like symptoms, tired, achey, feverish, sweaty, chills, swollen lip and itchy forearms was not reported. This report was non-serious.
Brown frothy urine that turned to blood, no fever, no infection. ER reported kidney inflammation but not known why.
Arm hurt for days but glad I got it; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 30-JUL-2022 Reporter's Comments:  The case was received from the patient via interactive digital media. The patient's arm hurt for days but patient was glad for getting vaccine.
Two weeks post vaccination the pt developed herpes zoster. One year later, the pt had herpes zoster again. The pt sought unspecified medical attention. Additional information has been requested.
13 day p/MMR pt devl t101 ax & papular rash also noted otitis media;
Product was not diluted prior to administration. Pt received 0.2 ml of undiluted Pfizer bivalent 5-11 year old vaccine ( "orange top")
the patient received the first dose of GARDASIL 9 in 2016; This spontaneous report was received from a patient of unknown age and gender referring himself/herself. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported.  In 2016, the patient was vaccinated with first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, dose, route, lot# and expiration date were not provided) 1 time dose for prophylaxis.         On 07-JUN-2021, the patient inquired if hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) dosing schedule was needed to be restarted (inappropriate schedule of product administration).
Sharp chest pain on 5/16/21 and 5/17/21 that caused me to catch my breath it lasted for a couple of minutes, then it stopped. The same thing happened 5/18/21 and 5/19/21 but because it was not as severe I did not seek medical attention.
Chills fever fatigue sore arm still feeling awful 4 days post injection- weakness and shortness of breath
pt recv vax NOV98 & devel gastroenteritis & was hosp in DEC98;
"2 different neurologists I have seen say they have treated patients who have had tremors for weeks"; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TREMOR ("2 different neurologists I have seen say they have treated patients who have had tremors for weeks") in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TREMOR ("2 different neurologists I have seen say they have treated patients who have had tremors for weeks"). At the time of the report, TREMOR ("2 different neurologists I have seen say they have treated patients who have had tremors for weeks") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product was reported. Treatment information was not provided.    This case was linked to MOD21-121801 (Patient Link).
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unspecified age. No information was provided regarding medical history, concurrent conditions, or concomitant medications.   On an unknown date, the patient was inoculated with zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster).  Shortly after receiving zoster vaccine live (ZOSTAVAX), the patient suffered an outbreak of shingles. As a result of these symptoms, the patient was seen and treated by medical providers and was still under their care. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations not present prior to using the product. The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of his condition. As a result of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of the Company's wrongful conduct, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the Company's conduct, the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the event was considered not recovered/not resolved.   The event was considered related to zoster vaccine live (ZOSTAVAX).   The event of shingles was considered to be disabling.
This spontaneous case was reported by a consumer and describes the occurrence of vaccination complication in a  patient of an unknown age and gender who received mRNA-1273  for COVID-19 vaccination. Concurrent medical conditions included Autoimmune disorder.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (3 other cases of autoimmune condition reactions). At the time of the report, VACCINATION COMPLICATION (3 other cases of autoimmune condition reactions) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication given. No treatment information given.   This case was linked to MOD21-161705.
This spontaneous report was received from a registered nurse refers to a patient of unknown age and gender. On 11-NOV-2014 the patient was vaccinated with PNEUMOVAX 23 lot # K006681, expiration date: 21-OCT-2015, 0..5 ml, intramuscular. On 11-NOV-2014 the patient received 2 doses of PNEUMOVAX 23 on the same day. The patient received two doses of PNEUMOVAX 23 instead of one dose of unspecified flu vaccine and one dose of PNEUMOVAX 23. This was related to staff error and not product confusion. No adverse effect reported. Additional information has been requested.
Administration of booster shot from vial punctured past 12 hours; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of booster shot from vial punctured past 12 hours) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of booster shot from vial punctured past 12 hours). On 23-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administration of booster shot from vial punctured past 12 hours) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.  HCP stated the vial was received and put in freezer on 5 Nov 2021 then was pulled out of freezer to thaw the day of being punctured at 11:30 AM on 22 Nov 2021. Total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F).   Most recent FOLLOW-UP information incorporated above includes: On 23-Nov-2021: Follow-up received which contains primary source, patient demographics and AE additional information were updated.
33yo M reported symptoms of throat tightness and difficulty swallow after recieving his vaccine. He was evaluated and monitored by medical staff and ems. Vitals were WNL with unremarkable PE.  He was given po fluids which he was able to swallow. After no improvement in symptoms, pt was given 60mg fexofenadine.
arm pain in 9 weeks after last Moderna shot; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (arm pain in 9 weeks after last Moderna shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (arm pain in 9 weeks after last Moderna shot). At the time of the report, MYALGIA (arm pain in 9 weeks after last Moderna shot) outcome was unknown.            Concomitant medication and treatment drug were not reported.
This is a spontaneous report by a contactable nurse. This nurse reported on behalf of a 84 year old female patient who was administered with a dose of PREVNAR 13 (LOT# G13185, expiration date: 31May2014) intramuscularly on right deltoid at 2.30 pm on 13Nov2012. Relevant medical history included hypertension, diabetes, high cholesterol which was still ongoing during the events onset. Relevant concomitant medications included glimepiride 2mg, PRAVACHOL 40mg, AZOR 5/40mg, LASIX 40mg, tramadol 50mg as needed, and potassium 10mEq all ongoing during the events onset. Vaccines given on the same day were none. Vaccines taken within the last four weeks were none. On 15Nov2012, she had excessive swelling, soreness and redness at the injection site, and 10 X 6 cm erythema in the area which covered entire arm, shoulder and elbow and "the area peeled". In Nov2012, she was diagnosed with breast cancer. On 21Nov2012, her white blood count was elevated. Therapeutic measures taken in response to excessive swelling, soreness and redness at the injection site included TYLENOL every 6 hours as needed, BENADRYL every 6 hours as needed, and ibuprofen as needed. Relevant lab data included complete blood count (CBC) test on 21 Nov2012 and the results showed that her white blood count was elevated and unspecified fasting lab tests on 21Nov2012 for which the results were unknown. At the time of the report the clinical outcome of breast cancer and white blood count was elevated was unknown, she was recovering from the other events.
Information has been received from a physician concerning a male patient with allergic reaction to antibiotics (name and manufacturer unspecified) who on 15-JAN-1998, when 11 month old, was vaccinated with the first dose of VARIVAX (Merck) (lot number not reported). On 27-SEP-2007 the patient was vaccinated with the second dose of VARIVAX (Merck) (lot number 658294/1103U). On 23-SEP-2009, when 12 year old, the patient developed mild case on chicken pox. It was also mentioned that week ago the patient was exposed to someone who had chicken pox. Unspecified medical attention was sought. There were no lab studies performed. At the time of the report, the patient had not recovered. Follow-up information received from a healthcare professional concerning the 12 year old male patient with allergy to BIAXIN who on 27-SEP-2007, at 16:30 pm was vaccinated IM with the second dose of VARIVAX (Merck) (lot number 658294/1103U). On 23-SEP-2009, at 9:00 am the patient's mother called the office stated that the patient had "chicken pox". The patient had blister like sports on back. The mother described what sounded like chicken pox-also the patient exposed to someone 2 week prior that was diagnosed with chicken pox. The patient was not seen for diagnosis. On 30-SEP-2009 the patient recovered. Additional information is not expected.
6hr p/vax pt noted inc swelling @ pain @ inj site states area was red warm & swelled to baseball size;notified p/4 days states better not seen by RN;
On 8/25/00 (lot ENG3359A4), 10/25/00 (lot ENG3359A4), 3/9/01 (lot ENG3360A4), 4/12/01 (lot ENG3383A4), 5/23/01 (ENG3382A4) and 10/23/01 (lot ENG5235A4), the vaccinee received his 1st, 2nd, 3rd, 4th, 5th and 6th injections of Engerix-B, respectively. On 3/6/02, 19 weeks after his 6th injection of Engerix-B, Hep-B surface antibodies were found to be "nonreactive". The reporter stated that the lack of efficacy could have been associated with erroneous administration ("did not shake bottle"). As of 4/22/02, the outcome of the event was unknown.
Narrative:  Presented to ER on 9/15/21 with loose stools/diarrhea for one month. Also reported cough, fatigue, and SOB. BP 86/46, and AKI likely due to dehydration. Comorbidities include Afib, HL, HTN, tobacco use, and peripheral neuropathy. CT reports bibasilar ground glass opacities. Dx with acute hypoxic respiratory failure due to acute COVID pneumonia. Admitted and treated with IV remdesivir (9/15 - 9/20) and dexamethasone daily (09/17 - 9/20). Supportive treatment with ascorbic acid, benzonatate, zinc sulfate, albuterol and supplemental O2 as needed. Discharged 9/21 on albuterol MDI, guaifenesin, and methylprednisolone dose pack.
Injection Site Pain, Hedache, Fatigue, Nausea & Vomiting
bunch of issues suddenly with memory and hallucinations; bunch of issues suddenly with memory and hallucinations; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): 02161374.  An elderly patient received BNT162b2 (BNT162B2), in Jun2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary series complete, Unknown Manufacturer), for COVID-19 Immunization. The following information was reported: HALLUCINATION (medically significant), MEMORY IMPAIRMENT (non-serious) all with onset Jun2022, outcome "unknown" and all described as "bunch of issues suddenly with memory and hallucinations".   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Irritability 3 days duration accompanied by episode of unconsolable crying of 45 min duration. NO fever, no seizure.
Since completion of the vaccine I have become sensitive to eggs. I developed nausea and an upset stomach almost immediately after consuming eggs. This was not an issue prior to the vaccination.
Pregnant; This spontaneous prospective pregnancy case was reported by an other health care professional and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 15-May-2021. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications was reported.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jul-2021: follow-up received.No new information added
This spontaneous report was received from a pharmacist concerning a 75 year old male patient with no pertinent medical history and drug reactions/allergies. On 16-SEP-2012, the patient was vaccinated with ZOSTAVAX (19400, units unspecified) (dose, route and lot number unspecified). No concomitant medications were reported. On 19-SEP-2012, the patient subsequently experienced the shingles. No treatment was provided. The patient sought medical attention. The outcome of shingles was reported as not resolved. The relatedness for the event was unknown for ZOSTAVAX. Additional information has been requested.
This spontaneous report was received from a nurse regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. The patient was vaccinated with three doses of GARDASIL on 31-DEC-2012, 08-MAR-2013 and 30-JUL-2013. Then on an unknown date the patient received fourth dose of GARDASIL 9, 0.5 ml, subcutaneously, with lot# L044475 and expiry date: 12-APR-2017. No adverse effects were reported. No further information provided. Additional information has been requested.